Candriam Luxembourg S.C.A. decreased its holdings in Xylem Inc. (NYSE:XYL) by 13.1% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 158,399 shares of the industrial products company’s stock after selling 23,939 shares during the period. Candriam Luxembourg S.C.A. owned approximately 0.09% of Xylem worth $9,921,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Harfst & Associates Inc. boosted its stake in shares of Xylem by 26.1% in the 2nd quarter. Harfst & Associates Inc. now owns 2,433 shares of the industrial products company’s stock valued at $134,000 after purchasing an additional 503 shares in the last quarter. CENTRAL TRUST Co boosted its stake in shares of Xylem by 160.3% in the 2nd quarter. CENTRAL TRUST Co now owns 2,655 shares of the industrial products company’s stock valued at $146,000 after purchasing an additional 1,635 shares in the last quarter. Tower Research Capital LLC TRC purchased a new stake in shares of Xylem in the 2nd quarter valued at $168,000. Federated Investors Inc. PA boosted its stake in shares of Xylem by 5.8% in the 2nd quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock valued at $182,000 after purchasing an additional 181 shares in the last quarter. Finally, Wesbanco Bank Inc. purchased a new stake in shares of Xylem in the 3rd quarter valued at $213,000. 86.49% of the stock is owned by institutional investors.
Shares of Xylem Inc. (NYSE:XYL) traded down $0.03 during trading on Friday, hitting $66.25. 504,000 shares of the company traded hands, compared to its average volume of 971,231. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.26 and a current ratio of 1.76. The company has a market cap of $11,898.50, a price-to-earnings ratio of 28.93, a price-to-earnings-growth ratio of 1.85 and a beta of 1.16. Xylem Inc. has a 52 week low of $46.67 and a 52 week high of $67.64.
Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, October 31st. The industrial products company reported $0.65 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.01. The company had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.18 billion. Xylem had a net margin of 6.85% and a return on equity of 17.74%. Xylem’s quarterly revenue was up 33.2% compared to the same quarter last year. During the same period last year, the business earned $0.54 EPS. equities analysts anticipate that Xylem Inc. will post 2.39 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 6th. Shareholders of record on Thursday, November 2nd will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Wednesday, November 1st. This represents a $0.72 dividend on an annualized basis and a yield of 1.09%. Xylem’s dividend payout ratio is currently 41.86%.
Several brokerages have weighed in on XYL. Cowen and Company reissued an “outperform” rating and set a $70.00 price target (up previously from $60.00) on shares of Xylem in a research report on Wednesday, August 9th. Oppenheimer Holdings, Inc. increased their price target on shares of Xylem from $66.00 to $75.00 and gave the company an “outperform” rating in a research report on Wednesday, November 1st. Boenning Scattergood reissued an “outperform” rating on shares of Xylem in a research report on Tuesday, September 5th. Royal Bank Of Canada increased their price target on shares of Xylem from $58.00 to $64.00 and gave the company an “outperform” rating in a research report on Wednesday, August 2nd. Finally, Canaccord Genuity reissued a “hold” rating and set a $65.00 price target on shares of Xylem in a research report on Wednesday, November 1st. Six research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $65.17.
TRADEMARK VIOLATION NOTICE: This piece of content was originally published by Markets Daily and is the property of of Markets Daily. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/11/12/candriam-luxembourg-s-c-a-cuts-stake-in-xylem-inc-xyl.html.
In other Xylem news, Director Steven R. Loranger sold 37,700 shares of the firm’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $66.25, for a total transaction of $2,497,625.00. Following the completion of the sale, the director now directly owns 58,831 shares in the company, valued at approximately $3,897,553.75. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Colin R. Sabol sold 38,070 shares of the firm’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $65.81, for a total transaction of $2,505,386.70. Following the sale, the insider now owns 61,979 shares of the company’s stock, valued at $4,078,837.99. The disclosure for this sale can be found here. 0.75% of the stock is currently owned by company insiders.
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.